Effect of Zafirlukast on improving lung function in patients with chronic obstructive pulmonary diseases

BACKGROUND: There is little evidence about the role of Zafirlukast (a highly selective LTD4 antagonist) in Chronic Obstructive Pulmonary Disease (COPD). The Zafirlukast can reduce the need for short-acting rescue β2 agonists, produce fewer exacerbations of asthma and increased quality of life as pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Moosavi, Seyed Ali Javad, Raji, Hanieh, Tasorian, Baharak, Mostafapour, Elyas, Shahabi, Shahab, Purfakharan, Mohammad, Fereshtehnejad, Seyed-Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610308/
https://www.ncbi.nlm.nih.gov/pubmed/23741166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610308/
https://www.ncbi.nlm.nih.gov/pubmed/23741166

Ejemplares similares